General
Preferred name
SELENOMETHIONINE
Synonyms
Selenomethionine Se-75 ()
L-SelenoMethionine ()
SELENOMETHIONINE SE 75 ()
NSC-760370 ()
Selenomethionine, l-, se-75 ()
Selenomethionine (75Se) Injection ()
Selenomethionine, se-75 ()
Sethotope ()
Radioselenomethionine 75 se ()
Selenomethionine (75Se) ()
75SE ()
Selenomethionine (75 se) ()
Selenomethionine,se-75 ()
P&D ID
PD000174
CAS
1464-42-2
1187-56-0
3211-76-5
Tags
natural product
drug
available
Approved by
FDA
Drug Status
investigational
approved
Max Phase
Phase 4
Drug indication
Radioactive Agent
Diagnostic Aid (pancreas function determination)
First approval
1973
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
12
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
55
Properties
(calculated by RDKit )
Molecular Weight
197.0
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
4
Ring Count
0
Aromatic Ring Count
0
cLogP
-0.04
TPSA
63.32
Fraction CSP3
0.8
Chiral centers
1.0
Largest ring
0.0
QED
0.62
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Apoptosis
Metabolic Enzyme/Protease
Target
Endogenous Metabolite
ROS
Source data
